搜索临床试验以:Canagliflozin 和二甲双胍缓释 (XR) 固定剂量组合 [FDC]
总计115个结果
-
Janssen Research & Development, LLC完全的
-
Janssen Research & Development, LLC完全的
-
Janssen Research & Development, LLC完全的
-
Janssen Research & Development, LLC完全的
-
Janssen Research & Development, LLC完全的
-
Actavis Inc.完全的
-
Woman'sPfizer; American Cancer Society, Inc.; Our Lady of the Lake Regional Medical Center撤销
-
Indiana Hemophilia &Thrombosis Center, Inc.主动,不招人
-
Janssen Research & Development, LLC完全的
-
Janssen Research & Development, LLC完全的
-
Boehringer IngelheimEli Lilly and Company完全的
-
Janssen-Cilag S.p.A.完全的
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)招聘中
-
Mayo ClinicNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Center for... 和其他合作者完全的
-
Nanjing First Hospital, Nanjing Medical University尚未招聘胰岛素抵抗 | 2型糖尿病
-
ANRS, Emerging Infectious DiseasesGilead Sciences; Ministry of Health, Thailand; Assistance Publique - Hôpitaux de Paris, FRANCE; Chiang...尚未招聘
-
Novartis Pharmaceuticals终止
-
Raymond T. Chung, MDMerck Sharp & Dohme LLC撤销
-
GlaxoSmithKline完全的
-
Trisha Wise-DraperAmerican Cancer Society, Inc.主动,不招人
-
Boehringer IngelheimEli Lilly and Company完全的